Search
中/EN
Contact/Message
Home
central pharmacy
Policies
Medical Institution
Franchise
Innovate
Recruit
News
Search
Home
central pharmacy
Policies
Medical Institution
Franchise
Innovate
Recruit
News
中/EN
Contact/Message
Innovate
Your current position:
Home
Innovate
International innovative drugs
Bekemv
Bekemv
departments:
内科
drug:
注射液
Active:
Eculizumab
indication:
Bekemv 是一种用于治疗成人和儿童阵发性睡眠性血红蛋白尿症 (PNH)
Licensor:
Amgen Technology (Ireland) UC
Approved Country/Region:
欧盟
Approval time:
2023-04-19